Skip to main navigation
Innovating Solutions for Wound & Burn Care

Menu

Skip to content
  • Home
  • About Us
  • Products
  • Investor Relations
  • Contact Us

Investor Relations

NASDAQ: MDWD
featured-image-1

Financials & Filings

Show all

2020

Second Quarter
  • Q2 MediWound 2020 Conference Call
  • MediWound Reports Second Quarter 2020 Financial Results and Provides Corporate Update
  • Form 6-K

Annual Reports

Title View

Notice of Annual General Meeting of Shareholders

  • Add Files
    Notice of Extraordinary General Meeting of Shareholders 229.4 KB

FORM 20-F

  • Add Files
    FORM 20-F 1.4 MB

Proxy Statements

Title View

Proxy Statements

  • Add Files
    Proxy Statements 616 KB

Annual Documents

Filing date View
Feb 25, 2020 View HTML
0001178913-20-000640.pdf
0001178913-20-000640.rtf
0001178913-20-000640.xls
EX-101.INS - XBRL INSTANCE DOCUMENT
Mar 25, 2019 View HTML
0001178913-19-000913.pdf
0001178913-19-000913.rtf
0001178913-19-000913.xls
EX-101.INS - XBRL INSTANCE DOCUMENT

Current Earnings & News

Filing date View
Jan 11, 2021 View HTML
0001178913-21-000081.pdf
0001178913-21-000081.rtf
Nov 10, 2020 View HTML
0001178913-20-003071.pdf
0001178913-20-003071.rtf
0001178913-20-003071.xls

Investor Relations

  • Press Releases
  • In The News
  • Events & Presentations
  • Corporate Governance
  • Financials & Filings
    • SEC Filings
    • Annual Reports and Proxies
    • Quarterly Results
    • Key Ratios
  • Stock Information
  • Analyst Coverage
  • Investor FAQs
  • Contact Us

Shareholder Tools

  • Printed Materials
  • Email
  • Print
 
Copyright © 2021, MediWound. All rights reserved. Terms of Use | Privacy Policy